ClinicalTrials.Veeva

Menu

Messaging Therapy for Depression and Anxiety: A Longitudinal Effectiveness Study

T

Talkspace

Status

Completed

Conditions

Depressive Symptoms
Anxiety Disorders

Treatments

Behavioral: psychotherapy via asynchronous message

Study type

Observational

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

Therapies delivered via technology have been developed to improve accessibility, however, there is limited research regarding messaging therapy in particular, and none that we know of utilizing a longitudinal effectiveness design. The aim of this study was to investigate the overall effectiveness of messaging therapy, identify any contributors to its effectiveness, and to evaluate a dosage effect for this type of treatment.

Enrollment

12,980 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed Depression and/or Anxiety Disorder

Exclusion criteria

  • Any psychosis related symptoms or disorders

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems